Navigation Links
Advanced BioHealing Appoints Kevin C. O'Boyle as Chief Financial Officer
Date:12/10/2010

WESTPORT, Conn., Dec. 10, 2010 /PRNewswire/ -- Advanced BioHealing, Inc. (ABH), a leader in commercializing cell-based therapies and delivering on the promise of regenerative medicine, today announced the appointment of Kevin C. O'Boyle, as Senior Vice President and Chief Financial Officer.

(Photo:  http://photos.prnewswire.com/prnh/20101210/LA15604)

"We are pleased to welcome Kevin to our team as we continue to build a leading commercial regenerative medicine organization," said Kevin Rakin, Chairman and Chief Executive Officer for ABH. "Kevin has an outstanding track record as CFO of companies executing high-growth strategies, focused on both organic and external opportunities, and accessing the equity markets."

ABH has grown revenue from zero in 2006 to over $130 million in 2010 and today employs more than 350 professionals. These strong results are based on growing demand for its FDA-approved product Dermagraft® for the treatment of diabetic foot ulcers.

"I am excited about joining the exceptional team at Advanced BioHealing," said Mr. O'Boyle. "Advanced BioHealing is a well-established leader in the field of regenerative medicine with the ability to improve patient lives with its cell-based therapy. I look forward to bringing my leadership experience to the company as it moves into its next phase of commercial growth."

Mr. O'Boyle has 15 years experience in the healthcare industry. From January 2003 until December 2009, Mr. O'Boyle served as the Chief Financial Officer of NuVasive, Inc., a medical device company focused on spinal applications, which completed its initial public offering in May 2004. He joined NuVasive when it had less than $30 million in annual revenue and was a key member of the management
'/>"/>

SOURCE Advanced BioHealing, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. Study Shows Novartis Drug Afinitor® Plus Hormonal Therapy Delays Disease Progression in Advanced Metastatic Breast Cancer Patients
2. New Subgroup Analysis of LUX-Lung 1 Trial Suggests Afatinib Increases Progression-Free Survival in Advanced Lung Cancer Patients More Likely to Have EGFR Mutations
3. Boehringer Ingelheim Initiates Phase III Clinical Trial With Afatinib in Advanced Breast Cancer
4. Data from Phase 2 Study of Alder Biopharmaceuticals Anti-IL-6 Antibody Therapeutic, ALD518, Demonstrate Reversal of Anemia in Patients with Advanced Non-Small Cell Lung Cancer
5. Phase 2 Data Presented at the 52nd Annual Meeting of the American Society of Hematology Demonstrates Promising Efficacy of KRX-0401 (Perifosine) in the Treatment of Advanced Leukemia, Lymphoma and Multiple Myeloma
6. US FDA Advisory Committee Makes Recommendation on New Drug Application for Vandetanib in Advanced Medullary Thyroid Cancer
7. Dawson James Initiates Research Coverage of Advanced Life Sciences
8. Advanced Life Sciences Applies for FDA Orphan Drug Designation for ALS-886 to Treat Acute Lung Injury
9. New Stereotactic Body Radiation Therapy (SBRT) Protocols Fuel Interest in Advanced Lung and Liver Treatments
10. Published Results Show Denosumab Superior to Zometa® in Delaying or Preventing Bone Complications in Patients With Bone Metastases From Advanced Breast Cancer
11. Advanced Life Sciences to Host 2010 Third Quarter Financial Results Conference Call and Webcast
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/19/2014)... 2014 Shire plc (LSE: SHP, NASDAQ: ... Financial Officer (CFO), has notified the Board of Directors of his ... new career opportunity as CFO of Severn Trent plc.  James will ... will commence a search for a new CFO immediately. ... helped build and lead a high-quality finance team at Shire. We ...
(Date:10/18/2014)... WASHINGTON , Oct. 18, 2014  In ... Human Rights Campaign (HRC), the nation,s largest lesbian, ... explicitly endorsed the use of Truvada for Pre-Exposure ... health tool used to prevent the spread of ... is the only brand name anti-HIV drug combination ...
(Date:10/17/2014)... 2014  Amgen (NASDAQ: AMGN ) today ... M.D., president of Gladstone Institutes and Gladstone,s Robert W. ... "We are pleased to welcome Dr. Sandy Williams ... Bradway , chairman and chief executive officer of Amgen. ... and his direct experience in our industry will both ...
Breaking Medicine Technology:Interim Chief Financial Officer James Bowling to Step Down 2Interim Chief Financial Officer James Bowling to Step Down 3Interim Chief Financial Officer James Bowling to Step Down 4HRC Endorses PrEP, Calls for Bold Action to Expand Access to Anti-HIV Drug 2HRC Endorses PrEP, Calls for Bold Action to Expand Access to Anti-HIV Drug 3Amgen Announces Appointment Of R. Sanders Williams To Board Of Directors 2Amgen Announces Appointment Of R. Sanders Williams To Board Of Directors 3
... 23, 2012  (OTC: IFIX) Internal Fixation Systems today announced ... to market subtalar implants. These implants are used to ... both trauma conditions and arthritis.  IFS CEO, Stephen Dresnick, ... to fill out our portfolio, and gives us another ...
... Dana Taschner from the Los Angeles office of ... California,s best lawyers in the annual Southern California Super Lawyers ... Taschner has earned the Super Lawyers distinction. He holds ... The Best Lawyers in America , one of the leading guides ...
Cached Medicine Technology:Internal Fixation Systems Announces 510(k) Approval Granted by FDA for Subtalar Implants 2The Lanier Law Firm's Dana Taschner Recognized Among Southern California's Top Lawyers 2
(Date:10/20/2014)... 2014 The Advocator Group, LLC ... the American Foundation for Suicide Prevention’s (AFSP) Out of ... a not-for-profit organization that hosts hundreds of community walks ... events are used to help understand and prevent suicide ... relationships as well. , The Advocator Group shares ...
(Date:10/20/2014)... (PRWEB) October 20, 2014 hc1.com ... a secure cloud solution that enables healthcare organizations ... the ultimate healthcare-specific customer relationship management (“CRM”) solution. ... the unique needs of the healthcare industry, the ... for providers and patients by combining healthcare CRM, ...
(Date:10/20/2014)... Principle Business Enterprises, a family owned company ... absorbent products. The company has recently made efforts ... Tranquility® Premium Protection absorbent products. The company has ... packaging a new look, and is currently working on ... public. , The new website, developed with Thread Marketing ...
(Date:10/20/2014)... (PRWEB) October 20, 2014 Succeed is proud ... local companies who participated in the Every Body Walk! ... a public awareness project that encourages workers to be more ... Step 10,000 Program, which concluded at the end of September, ... of cities and metro areas. Participating companies gave their ...
(Date:10/20/2014)... 20, 2014 Unveiled at the Sept. 18 ... Scorecard conservatively estimates member hospital ROI on membership dues at ... The Center provides $12.50 in value to member hospitals. The ... – Member Dues)/Member Dues. , “This is the first ... and we think the methodology is really sound,” said ...
Breaking Medicine News(10 mins):Health News:The Advocator Group, LLC is Proud to Participate in an Out of the Darkness Community Walk, October 25th, to Increase Suicide Awareness 2Health News:The Advocator Group, LLC is Proud to Participate in an Out of the Darkness Community Walk, October 25th, to Increase Suicide Awareness 3Health News:Healthcare Relationship Management (HRM) Leader hc1.com® Launches hc1® Quick Start™ 2Health News:Tranquility® Premium Protection Incontinence Products Releases New Logo and Website 2Health News:Succeed Management Solutions, LLC Competes in Walking Challenge and Achieves 12th Place in Portland 2Health News:Scorecard Estimates Hospital ROI at $12.50 for every $1 Spent on Dues 2Health News:Scorecard Estimates Hospital ROI at $12.50 for every $1 Spent on Dues 3Health News:Scorecard Estimates Hospital ROI at $12.50 for every $1 Spent on Dues 4
... a division of Patient Safety Technologies, Inc. (OTC Bulletin Board:,PSTX), ... has become,one of its partners in helping to create a ... sponsor at Leapfrog,s next two meetings in,December and February. , ... and privileged to enter into an affiliation with,Leapfrog. We share ...
... 4 Qforma, an advanced analytics and predictive modeling ... Vice President of Sales, New Business. , ... the pharmaceutical industry and is an ideal addition to Qforma,s ... brings nearly two decades of industry experience and an impressive ...
... ALLEGAN, Mich., Dec. 4 The Perrigo Company,(Nasdaq: ... litigation relating,to Desloratadine tablets (5 mg) has been settled ... Perrigo had been sued for patent infringement of,US Patent ... of an ANDA,containing a Paragraph IV certification. Under ...
... Dec. 4 Decision Resources, one of the,world,s ... and,healthcare issues, finds that Eisai/Helsinn Healthcare,s Aloxi,s marketing,message ... the most influential,by oncologists in the chemotherapy-induced nausea ... with the brand,highlighting the strength of the Aloxi ...
... a,leading provider of managed care market intelligence, reports that ... through the,second quarter of 2008. According to the latest ... be sustained as the economy slows and,healthcare spending decreases. ... is critical in Florida because small businesses,represent about 90 ...
... Dec. 4 Continuing concern over preventable,harm to ... government agency to,emulate a leading aviation safety system. ... the Quality Chasm" series of reports, is,the Patient ... authorized the,creation of Patient Safety Organizations (PSOs). PSOs ...
Cached Medicine News:Health News:SurgiCount Medical Joins The Leapfrog Group 2Health News:Qforma Appoints Kent Harris as Senior Vice President of Sales 2Health News:Perrigo Settles Desloratadine Patent Litigation 2Health News:Perrigo Settles Desloratadine Patent Litigation 3Health News:Oncologists Rank Aloxi's Marketing Message Most Influential in the Chemotherapy-Induced Nausea and Vomiting Drug Market 2Health News:Florida's Small-Group Health Insurance Grew in First Half of 2008, Though Economic Downturn Likely to Halt Upward Trend 2Health News:Florida's Small-Group Health Insurance Grew in First Half of 2008, Though Economic Downturn Likely to Halt Upward Trend 3Health News:Hospitals Now Able to Analyze Medical Mistakes without Fear of Lawsuits 2Health News:Hospitals Now Able to Analyze Medical Mistakes without Fear of Lawsuits 3Health News:Hospitals Now Able to Analyze Medical Mistakes without Fear of Lawsuits 4
Ahmed Glaucoma Valve (small size)....
... established. Provides a robust and durable drainage ... on the globe. Pressure Ridge Molteno Implants ... by Tenons tissue, acts as a Pressure ... range of implants allows the surgeon to ...
... a robust and durable drainage system. Preplaced ... globe. Pressure Ridge Molteno Implants have a ... tissue, acts as a Pressure sensitive biological ... implants allows the surgeon to choose the ...
... Baerveldt Glaucoma Implants feature a low ... and reduced complications. The single-quadrant insertion is ... area seton plate to be installed with ... patented fenestrations of the Baerveldt implant were ...
Medicine Products: